Jennifer S Buell
4PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 14, 2025
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity.Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet
|Jul 10, 2025
Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor.Benjamin Garmezy, Joseph E Grossman, Jennifer Buell
|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.Dhan Chand, David A Savitsky, Shanmugarajan Krishnan
|Jan 28, 2024
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT).Matthew J Hadfield, Howard Safran, Marco A Purbhoo
Pageof 1
Frequent Collaborators
2 joint publications
Justin G Keith
2 joint publications
Justin Stebbing
2 joint publications
Marco A Purbhoo
2 joint publications
Joseph E Grossman
2 joint publications
Vignesh Venkatraman
2 joint publications
Dhan Chand
2 joint publications
Alvaro Sebastian-Yague
2 joint publications
Shanmugarajan Krishnan
2 joint publications
Bishnu Joshi
2 joint publications
Kah Teong Soh
